Moderna Inc (NASDAQ: MRNA) announced its intentions to launch up to 15 new products and advance up to 50 mRNA medicines into clinical trials over the next five years.
JPMorgan Chase & Co. (NYSE: JPM) reported better-than-expected results for its first quarter on Friday.
The bank reported Q1 net revenue (managed) of $39.3 billion, up 25% Y/Y, beating the consensus of $36.2 billion. EPS of $4.10 beat the consensus of $3.41.